Tumefactive demyelination and glioblastoma: A rare collision lesion

Clinical Neuropathology

Volumn 30, Issue 4, 2011, Pages 186-191

  Roemer, S F ^a   Scheithauer, B W ^a   Varnavas, G G ^b   Lucchinetti, C F ^a  

^a MAYO CLINIC   (United States)

^b Department of Neurosurgery   (United States)

Author keywords

Brain neoplasm; Inflammatory demyelination; Neoplastic transformation; Tumefactive demyelinating disease

Indexed keywords

DEXAMETHASONE; GADOLINIUM; TEMOZOLOMIDE;

ADULT; ARTICLE; ASTROCYTE; BRAIN EDEMA; CANCER SURGERY; CASE REPORT; DEMYELINATION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLIOBLASTOMA; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MORPHOLOGY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINUS HEADACHE; STEREOTACTIC BIOPSY;

ASTROCYTES; BIOPSY; BRAIN NEOPLASMS; COMORBIDITY; DEMYELINATING DISEASES; FATAL OUTCOME; FEMALE; GLIOBLASTOMA; HISTIOCYTES; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED;

EID: 80052329931     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: 10.5414/NP300201     Document Type: Article

References (20)

1. Kepes JJ. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol. 1993; 33: 18-27.
2. Lucchinetti CF, Gavrilova RH, Metz I, Parisi JE, Scheithauer BW, Weigand S, Thomsen K, Mandrekar J, Altintas A, Erickson BJ, König F, Giannini C, Lassmann H, Linbo L, Pittock SJ, Brück W. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain. 2008; 131: 1759-1775.
3. Peterson K, Rosenblum MK, Powers JM, Alvord E, Walker RW, Posner JB. Effect of brain irradiation on demyelinating lesions. Neurology. 1993; 43: 2105-2112.
4. Zagzag D, Miller DC, Kleinman GM, Abati A, Donnenfeld H, Budzilovich GN. Demyelinating disease versus tumor in surgical neuropathology. Clues to a correct pathological diagnosis. Am J Surg Pathol. 1993; 17: 537-545.
5. Shuangshoti S, Hjardermaal GM, Ahmad Y, Arden JL, Herman MM. Concurrence of multiple sclerosis and intracranial glioma. Report of a case and review of the literature. Clin Neuropathol. 2003; 22: 304-308.
6. Lucchinetti C, Brück W, Parisi J, Scheithauer B,Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 2000; 47: 707-717.
7. Aarli JA, Mørk SJ, Myrseth E, Larsen JL. Glioblastoma associated with multiple sclerosis: coincidence or induction? Eur Neurol. 1989; 29: 312-316.
8. Anderson M, Hughes B, Jefferson M, Smith WT, Waterhouse JA. Gliomatous transformation and demyelinating diseases. Brain. 1980; 103: 603-622.
9. Malmgren RM, Detels R, Verity MA. Co-occurrence of multiple sclerosis and glioma - case report and neuropathologic and epidemiologic review. Clin Neuropathol. 1984; 3: 1-9.
10. Lahl R. Combination of multiple sclerosis and cerebral glioblastoma. Eur Neurol. 1980; 19: 192-197.
11. Kleihues P, Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro-oncol. 1999; 1: 44-51.
12. Fassas AB, Gattani AM, Morgello S. Cerebral demyelination with 5-fluorouracil and levamisole. Cancer Invest. 1994; 12: 379-383.
13. Ng S, Butzkueven H, Kalnins R, Rowe C. Prolonged interval between sentinel pseudotumoral demyelination and development of primary CNS lymphoma. J Clin Neurosci. 2007; 14: 1126-1129.
14. Lalitha VS, Rubinstein LJ. Reactive glioma in intracranial sarcoma: a form of mixed sarcoma and glioma ("sarcoglioma"): report of eight cases. Cancer. 1979; 43: 246-257.
15. Eddleston M, Mucke L. Molecular profile of reactive astrocytes - implications for their role in neurologic disease. Neuroscience. 1993; 54: 15-36.
16. Kurtkaya-Yapicier O, Scheithauer BW, Hebrink D, James CD. p53 in nonneoplastic central nervous system lesions: an immunohistochemical and genetic sequencing study. Neurosurgery. 2002; 51: 1246-1254; discussion 1254-1245.
17. Graeber MB, Scheithauer BW, Kreutzberg GW. Microglia in brain tumors. Glia. 2002; 40: 252-259.
18. Tran CT, Wolz P, Egensperger R, Kösel S, Imai Y, Bise K, Kohsaka S, Mehraein P, Graeber MB. Differential expression of MHC class II molecules by microglia and neoplastic astroglia: relevance for the escape of astrocytoma cells from immune surveillance. Neuropathol Appl Neurobiol. 1998; 24: 293-301.
19. Del Valle L, Baehring J, Lorenzana C, Giordano A, Khalili K, Croul S. Expression of a human polyomavirus oncoprotein and tumour suppressor proteins in medulloblastomas. Mol Pathol. 2001; 54: 331-337.
20. Kleihues P, Soylemezoglu F, Schäuble B, Scheithauer BW, Burger PC. Histopathology, classification, and grading of gliomas. Glia. 1995; 15: 211-221.